SONOGRAPHIC ASSESSMENT OF GASTRIC FUNCTION IN PATIENTS FOLLOWING MAJOR COLORECTAL SURGERY
N Mirbagheri,1 G Dunn,2 M Suen1 and MA Gladman1
1Academic Colorectal Unit, Sydney Medical School – Concord, The University of Sydney, New South Wales, Australia; 2Department of Radiology, Concord Repatriation General Hospital, Concord, New South Wales, Australia
Introduction: Gastrointestinal dysfunction, manifesting as paralytic ileus, is a common morbidity after abdominal surgery. Currently, there is no objective, bedside tool to assess gastrointestinal function. This study aimed to evaluate bedside sonographic measurement of liquid gastric emptying, as a surrogate marker of gastrointestinal function, in patients following major colorectal surgery.
Methods: Following administration of 250 mls of water, gastric antral cross-sectional area was measured 10 minutely using a portable machine (The Edge®, SonoSite). Time to complete emptying (T100% water) was used as an objective marker of liquid gastric emptying. 30 healthy volunteers (HV) were studied to establish a normal range. Gastric function was assessed before and after major colorectal surgery in 30 patients.
Results: Median T100% water for 30 HV was 20 min, giving a normal range of 10–40 min. 30/39 patients completed the study protocol. Median (range) T100% water for the patient group before surgery was 20 (10–40) min with all patients falling within the normal range. On postoperative Day 1, T100% water was significantly prolonged with a median of 45 (10 to >60 min, P < 0.0001); notably T100% water was outside of the normal range in 15 patients (50%). On Day 2, gastric function was normal in 20 patients (67%). This group had less nausea (P = 0.0003), days to flatus (P = 0.011), earlier diet (P = 0.001), fewer cases of ileus (P = 0.002) and shorter hospital stay (P = 0.040).
Conclusion: Sonographic assessment of gastric emptying is feasible and its use in postoperative patients identified differences compared to normal/pre-op values. Patients with normal emptying on Day 2 had earlier return of gut function and hospital discharge.
RANDOMISED CONTROLLED TRIAL OF PERIOPERATIVE SIMVASTATIN THERAPY IN MAJOR COLORECTAL SURGERY
P Singh,1 D Lemanu,1 M Soop,2 I Bissett,3 J Harrison4 and AG Hill1
1Department of Surgery, Middlemore Hospital, Counties Manukau District Health Board, New Zealand; 2Department of Surgery, North Shore Hospital, Waitemata District Health Board, New Zealand; 3Department of Surgery, Auckland City Hospital, Auckland District Health Board, New Zealand; 4School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand
Introduction: Statins have numerous benefits relevant to abdominal surgery and in retrospective clinical studies, their use has been associated with a reduction in the systemic inflammatory response syndrome (SIRS), wound infection and anastomotic leak following colorectal surgery1,2. This study aimed to prospectively investigate whether perioperative statin therapy can attenuate the surgical pro-inflammatory response and reduce complications following major colorectal surgery.
Methods: A multi-centre, double-blind, randomized controlled trial was conducted at three tertiary hospitals in the Auckland Region between October 2011 and August 2013. Patients undergoing elective colorectal resection for any indication or reversal of Hartmann’s procedure were randomized to receive either 40 mg oral simvastatin or placebo once daily for 3–7 days before surgery till 14 days after surgery. The primary outcome was the total incidence of complications for 30-days postoperatively. Secondary outcomes included the systemic and peritoneal cytokine response (IL-1α, IL-1β, IL-6, IL-8, IL-10, TNFα), measured on postoperative day 1.
Results: There were 132 patients included in the study (65 simvastatin, 67 placebo). There were no significant differences between the two groups at baseline. There were no significant differences between the two groups in the incidence, grade and type of postoperative complications. Systemic levels of IL-6, IL-8 and TNFα, and peritoneal concentrations of IL-6 and IL-8, were significantly lower in the simvastatin group postoperatively. CRP levels were significantly lower in the simvastatin group on postoperative days 1 to 3.
Conclusion: Perioperative simvastatin therapy in major colorectal surgery attenuates the early pro-inflammatory response to surgery but does not reduce postoperative complications.
References
1. Singh PP, Srinivasa S, Lemanu DP et al. Statins in abdominal surgery: a systematic review. J. Am. Coll. Surg. 2012; 214: 356–66.
2. Singh PP, Srinivasa S, Bambarawana S et al. Perioperative use of statins in elective colectomy. Dis. Colon Rectum. 2012; 55: 205–10.
DEMOGRAPHICS AND TRENDS IN THE ACUTE PRESENTATION OF DIVERTICULAR DISEASE – A NATIONAL STUDY
R Vather,1 JB Broad,2 R Jaung,1 J Robertson1 and IP Bissett1
1Department of Surgery, University of Auckland, New Zealand; 2Freemasons’ Department of Geriatric Medicine, University of Auckland
Introduction: Diverticular disease (DD) is a major health problem in the Western world. This study aimed to describe demographics and trends in acute DD admissions in New Zealand.
Methods: Information pertaining to acute hospital admissions between January 2000 and June 2012 for a primary diagnosis of large bowel DD was retrieved from an ICD-10 coded national database. This contained electronic records of clinical discharge summaries from all New Zealand public hospitals and included patients with acute diverticulitis, diverticular bleeds and obstruction due to DD.
Results: There were 25,167 acute admissions for DD. Mean age was lower in men than women (61.4 vs 67.4 years, p < 0.001). Although men comprised 45.2% of the cohort they were over-represented in the 18–44 year group (68.6% vs 31.4%; p < 0.001). The number of admissions per year increased by 1,300 (7.5%/year) between 2001 and 2011. This exceeded New Zealand’s rate of population growth (0.8%/year). Admissions were higher in more deprived populations (p < 0.001). During the study period LOS reduced from 5.8 days to 4.1 days (p < 0.001), CT scanning doubled (29.7% to 59.2%; p < 0.001), the use of inpatient colonoscopy (26.1% to 13.2%; p < 0.001) and emergent surgery (14.8% to 7.2%; p < 0.001) were halved and percutaneous drain use increased from 0.6% to 1.1% (p = 0.003).
Conclusion: Acute DD is a source of considerable morbidity in New Zealand and the number of hospital admissions has increased dramatically over the last decade. There is also an unexpectedly high rate of admissions for young males. These findings have important implications for service provision.
TEMPORARY DIVERSION ILEOSTOMY IS AN INDEPENDENT LONG-TERM PREDICTOR FOR THE DEVELOPMENT OF ANTERIOR RESECTION SYNDROME
CI Wells, R Vather, MJJ Chu, JP Robertson and IP Bissett
Department of Surgery, The University of Auckland, New Zealand
Introduction: Evacuatory dysfunction after distal colorectal resection varies from incontinence to obstructed defaecation and is termed anterior resection syndrome. This study aimed to identify risk factors for the development of anterior resection syndrome.
Methods: All anterior resections undertaken at Auckland Hospital from 2002–2012 were retrospectively evaluated. An assortment of patient and peri-operative variables were recorded. Cases were stratified by occurrence of anterior resection syndrome symptoms from 1–5 years post-operatively.
Results: 277 patients were identified. Prevalence of anterior resection syndrome decreased progressively from 61% at 1 year to 43% at 5 years. Univariate analysis identified anastomotic height, surgeon, pT stage, procedure year and temporary diversion ileostomy as recurring significant correlates (p < 0.05). Logistic regression identified lower anastomotic height (OR 2.12, 95% CI 1.05–4.27; p = 0.04) and obstructive presenting symptoms (OR 6.71, 95% CI 1.00–44.80; p = 0.05) as independent predictors at 1 and 2 years respectively. Post-operative chemotherapy was a predictor at 1 year (OR 1.93, 95% CI 1.04–3.57; p = 0.03). Temporary diverting ileostomy was an independent predictor at 2 (OR 2.49, 95% CI 1.04–5.95; p = 0.04), 3 (OR 4.17, 95% CI 1.04–16.78; p = 0.04), 4 (OR 8.05, 95% CI 1.21–53.6; p = 0.03), and 5 years (OR 49.60, 95% CI 2.17–1134.71; p = 0.015) after correcting for anastomotic height.
Conclusion: Anastomotic height, post-operative chemotherapy and obstructive presenting symptoms were independent predictors at 1 and 2 years. Temporary diversion ileostomy was an independent predictor for the occurrence of anterior resection syndrome at 2, 3, 4, and 5 years even after correcting for anastomotic height. Prospective assessment is required to facilitate more accurate risk factor analysis.
COMPARING ONCOLOGICAL OUTCOMES OF LAPAROSCOPIC VERSUS OPEN SURGERY FOR COLON CANCER: ANALYSIS OF A LARGE PROSPECTIVE DATABASE
T Sammour,1 IT Jones,1 P Gibbs,2 R Chandra,3 MC Steel,3 SM Shedda,1 M Croxford,4 I Faragher,4 IP Hayes1 and IA Hastie1
1Colorectal Unit, Department of Surgery, The Royal Melbourne Hospital, Parkville, Victoria, Australia; 2Walter + Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; 3Colorectal Unit, Department of Surgery, Box Hill Hospital, Box Hill, Victoria, Australia; 4Colorectal Unit, Department of Surgery, Western Health, Gordon Street, Footscray, Victoria, Australia
Introduction: Laparoscopic surgery is increasingly utilized in the treatment of colon cancer, with level one evidence of improved short term outcomes compared to open surgery. Oncological outcomes have also been shown to be equivalent, but only in the setting of randomized controlled trials on highly selected patients. The aim of this study is to investigate whether this finding holds true in a more general clinical practice.
Methods: Analysis of prospectively collected data on colon cancer surgery between 2003 and 2009 was undertaken, utilizing the linkage and analysis resources of the BioGrid Australia oncological database. Five year overall survival, and cancer specific survival rates for open and laparoscopic surgery were compared, and Cox regression analysis performed to control for the confounders of age, sex, body mass index (BMI), ASA score, hospital site, year surgery performed, procedure, tumour stage, and adjuvant chemotherapy.
Results: During the study period 1387 patients underwent resection for colon cancer. There were significant differences between the laparoscopic and open cohorts in BMI, procedure performed, post-operative complication rate, and tumour stage. Five year overall survival was higher in the laparoscopic group (75.9% vs 69.2%, P = 0.015), with no difference in cancer specific survival (82.7% vs 78.3%, P = 0.074). Cox regression analysis showed no difference in 5 year overall survival (P = 0.254), or cancer specific survival (P = 0.866) when confounders were accounted for.
Conclusion: This large prospective clinical study validates previous trial results, and confirms that there is no difference in oncological outcome between laparoscopic and open surgery for colon cancer.
THE OESTROGEN RECEPTOR: A NOVEL THERAPEUTIC TARGET IN OESOPHAGEAL ADENOCARCINOMA
SL Due, DI Watson, I Bastian, O Sukocheva and DJ Hussey
Department of Surgery, Flinders University, Adelaide, South Australia, Australia
Introduction: Oesophageal adenocarcinoma (OAC) is a highly lethal malignancy and is increasing in incidence faster than any other cancer. Preliminary data from our laboratory indicate that OAC tissues and cell lines express oestrogen receptors (ERs), and therefore may respond to therapy with selective oestrogen receptor modulators (SERM).
Methods: Immunohistochemistry was used to identify ERα and ERβ in human OAC resection specimens. ER expression in OAC cell lines was characterized by Western analysis. OAC cell lines were subcultured and treated with SERM and conventional chemotherapy agents. Treatment effects were assessed with an MTS cell proliferation assay and dose-response curves generated. Cell killing via apoptosis was confirmed using annexin V/PI flow cytometry.
Results: Human OAC specimens were found to express ERα and ERβ. ERs were also identified in ten OAC cell lines. Treatment experiments were conducted in two cell lines (OE-19 and OE-33), which expressed both ERα and ERβ. IC50 values for OE-19 and OE-33 were 11.2 and 7.1 μM for tamoxifen, 19.6 and 4.7 μM for cisplatin, and 1.7 and 5.9 μM for 5-fluorouracil (5-FU), respectively. Apoptosis was detected in 28.4% and 60% of cells treated with tamoxifen, 26.1% and 28.6% cells treated with cisplatin, and 22.2% and 27.3% cells treated with 5-FU at their IC50 concentrations. Combined SERM and chemotherapy treatment demonstrated an additive effect on cell death.
Conclusions: ERs are present in OAC cells, and these cells respond to treatment with SERM in vitro. The addition of SERM to existing chemotherapy drugs in this setting appears to be feasible.
DEVELOPING A PROTOCOL FOR THE IDENTIFICATION, PHENOTYPING AND CULTURE OF TUMOUR INFILTRATING LYMPHOCYTES FROM RESECTED MELANOMA METASTASES
DE Gyorki,1,2 JA Westwood,3 P Petrone,3 P Neeson,3 PK Darcy,3 J Spillane,1 MA Henderson1 and MH Kershaw3
1Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victoria, Australia; 2Cancer Immunology Research Program, Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia; 3Department of Surgery, University of Melbourne, Victoria, Australia
Introduction: Melanoma is a highly immunogenic malignancy. Tumour infiltrating lymphocytes (TIL) are located within melanomas and recognize a variety of epitopes on the tumour cell. TIL are unable to perform their normal immune function due to a variety of immunosuppressive mechanisms employed by the tumour. We sought to identify and phenotype TIL from resected melanoma specimens and grow them in culture to create a translational research tool.
Methods: Patients undergoing surgical resection for metastatic melanoma were prospectively recruited to the study. A portion of the resected specimen was delivered fresh and sterile from the operating theatre to the laboratory. A single cell suspension was created to allow phenotyping of TIL using flow cytometry with a dedicated panel of immune markers. Fragments of tumour were placed in cell culture from which TIL irrupted and proliferated, using interleukin-2 as a growth factor.
Results: Of 13 patients recruited, 11 have had evaluable tissue. The specimens were subcutaneous (45%), nodal (36%), intramuscular (9%) and lung (9%). TIL were successfully grown in culture in 100% of evaluable cases. A flow cytometry panel was able to classify TIL into effector and regulatory T cell subsets and further characterize these using markers of activation and differentiation. We identified a wide variation in TIL phenotype between melanoma specimens.
Conclusion: A protocol for the fresh and sterile transfer of tissue from the operating theatre to the laboratory allows molecular characterization of TIL from resected melanoma specimens. This is an invaluable tool to study tumour–host interactions in patients with advanced melanoma.
NEW PREDICTIVE AND PROGNOSTIC MARKERS FOR ACC IDENTIFIED UTILISING IMMUNOHISTOCHEMISTRY AND TISSUE MICROARRAY TECHNOLOGY
JCY Ip,1,2 TCY Pang,2,4 AR Glover,1,2,3 JC Lee,1 JS Gundara,1,2 JT Zhao,1,2 P Soon,5 BG Robinson,1,2 AJ Gill6 and SB Sidhu1,2,3
1Kolling Institute of Medical Research, Royal North Shore Hospital and The University of Sydney, New South Wales, Australia; 2Faculty of Medicine, Northern Clinical School, The University of Sydney, Sydney, New South Wales, Australia; 3Endocrine and Oncology Surgical Unit, Royal North Shore Hospital and The University of Sydney, New South Wales, Australia; 4Department of Surgery, Westmead Hospital, University of Sydney, New South Wales, Australia; 5South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia; 6Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Introduction: Adrenocortical carcinoma (ACC) is a rare but highly lethal malignancy with limited treatment options. The aim of this study was to identify novel protein signatures that would predict clinical outcomes in a large cohort of patients with ACC.
Methods: A tissue microarray was generated from the paraffin tissue blocks of 61 patients with complete clinical data. Based on the results of previous gene expression microarray profiling studies, candidate protein biomarkers were identified using immunohistochemistry. Patterns of staining were compared with clinical outcomes and a multivariate analysis undertaken to identify potential predictive and prognostic biomarkers.
Results: Median overall survival was 45 months, with the 5-year overall survival being 44%. Median disease-free survival was 58 months, with a 44% 5-year disease-free survival. The proliferation marker Ki-67 and DNA topoisomerase TOP2A were associated with significantly poorer overall and disease-free survival. There was also a strong correlation between the transcriptional repressor EZH2 and TOP2A expression, suggesting a novel role for EZH2 as an additional marker of prognosis. In contrast, increased expression of the BARD1 protein, with its ubiquitin ligase function, was associated with significantly improved overall and disease-free a survival, which has yet to be documented for ACC.
Conclusion: We report on a novel panel of protein markers that have been validated in a cohort of patients with ACC that are able to predict both poor and improved survival outcomes. It is hoped that these new markers will aid in tailoring additional therapy as well as being potential targets of molecular therapy themselves.
IMPACT OF INCONSISTENCIES IN CLINICOPATHOLOGICAL DATA ON SURVIVAL AND MOLECULAR ANALYSES
DM Wright,1,2 SY Mehta,1 F Munro,2 AEH Merrie,3 CG Print1 and J McCall2
1School of Medical Sciences, The University of Auckland, New Zealand; 2Department of Surgical Sciences, University of Otago, New Zealand; 3Auckland District Health Board, New Zealand
Introduction: Translational research efforts are being made to combine biological and clinical data to improve outcomes for cancer patients, however cancer databases report error rates of up to 27% in clinical datasets. Despite this, inadequate attention is paid to the impact of these errors on translational research findings.
Methods: Review of the clinicopathological annotations of 206 prospectively collected colorectal cancer samples from a New Zealand cohort elucidated the presence of data inconsistencies. The aim of this study was to carefully revise these data, to evaluate the impact of data revision on survival analyses and gene expression associations, and to implement processes to avoid error and omission during future data collection.
Results: Staging data was found to be missing from 50% of samples, and disease recurrence data from 25%. Survival analyses showed significant differences between the original and revised datasets. Disease free survival (DFS) at five years was 62% in the original dataset and 83% in the revised data set (P = 0.005). For 106 of these tumours, revision of clinicopathological tumour annotation alone was found to result in a statistically significant association between DFS and APC expression (P < 0.05) that was not apparent in the original data (P = 0.09).
Conclusion: This study demonstrates that accurate clinicopathological data play a critical role in translational research. Moreover, these results support the need for optimal methods to prevent, detect and correct inaccuracies in the clinicopathological annotations used for translational research to be established, as are being implemented to our dataset.
APR-246/PRIMA-1MET DELAYS GROWTH AND INDUCES APOPTOSIS IN OESOPHAGEAL ADENOCARCINOMA EXPRESSING MUTANT P53
DSH Liu,1 N Clemons,1 M Read,1 C Fennell,1 C Cullinane,2 CP Duong1 and WA Phillips1
1Surgical Oncology Research Laboratory, Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victoria, Australia; 2Translational Research Laboratory, Division of Cancer Research, Peter MacCallum Cancer Centre, Victoria, Australia
Introduction: Oesophageal adenocarcinoma (OAC) has poor clinical outcomes with limited treatment options. p53, a master tumour suppressor protein is mutated in 70% of OAC, resulting in resistance to chemo-radiotherapies and poor patient survival. In this study, we evaluated the potential therapeutic effects of restoring wild-type activity to mutant p53 protein in OAC, using the small molecular compound APR-246.
Methods: Twelve cell lines (8 mutant, 3 null and 1 wild-type p53) were treated with APR-246, and their response measured using clonogenic survival, proliferation, cell cycle and apoptosis assays. Ectopic expression and gene knockdown studies of mutant p53 were performed to interrogate p53-dependent drug effects. Wild-type p53 target gene expression was examined using RT-qPCR and western blot. The growth inhibitory effects of combining APR-246 with conventional chemotherapies were also evaluated while in-vivo drug activity was assessed using cell line and patient derived xenograft models.
Results: APR-246 preferentially induced apoptosis in OAC cells harbouring p53 mutations and led to expression of wild-type p53 target genes. Sensitivity to APR-246 correlated with cellular levels of mutant p53 protein. Ectopic expression of mutant p53 genes sensitized p53-null cells to APR-246, whilst p53 gene knockdown diminished drug activity. Importantly, APR-246 synergistically enhanced the inhibitory effects of cisplatin, 5-fluorouracil and epirubicin in a mutant p53 dependent manner. Finally, APR-246 demonstrated potent anti-tumour activity in cell line and patient derived xenograft models, and restored chemo-sensitivity to a cisplatin/5-fluorouracil resistant xenograft model.
Conclusion: Restoring wild-type activity to mutant p53 protein using APR-246 is a promising therapeutic strategy for OAC.
VALIDATION OF A VIRTUAL REALITY SIMULATION MODEL FOR LAPAROSCOPIC APPENDICECTOMY AND INCORPORATION INTO A PROFICIENCY-BASED CURRICULUM
P Sirimanna,1 R Aggarwal2 and MA Gladman1
1Academic Colorectal Unit, Sydney Medical School – Concord, University of Sydney; 2Department of Surgery, Faculty of Medicine, McGill University, Montreal, Canada
Introduction: Proficiency-based training curricula using virtual reality (VR) simulation improves operating theatre performance. Surprisingly, training in laparoscopic appendicectomy (LA) has received little attention. This study aimed to validate a VR LA model as a training and assessment tool and identify benchmarks of proficiency prior to incorporation into a training curriculum.
Methods: 10 experienced (>50 LAs), 8 intermediate (10–30 LAs) and 20 inexperienced (<10 LAs) operators were recruited. Construct validity of a high-fidelity VR LA simulator (consisting of guided/unguided modules) was determined by the ability to differentiate levels of experience, based on simulator-derived metrics (number of movements, path-length, idle and task time). Inexperienced operators performed 10 repetitions for learning curve analysis. Proficiency benchmarks were defined by experienced operator performance.
Results: All guided modules demonstrated construct validity for all metrics (P < 0.05), with learning curves that plateaued between sessions 6 and 9 (P < 0.01). The unguided LA module demonstrated construct validity for number of movements (1101 vs 690.5 vs 532, P < 0.01), path-length (1797.1 cm vs 1573.5 cm vs 1315.1 cm, P < 0.01), idle time (325.4 s vs 160.4 s vs 118.5 s, P < 0.01) and task time (864.5 s vs 477.2 s vs 352.1 s, P < 0.01), with learning curves that failed to plateau. Proficiency benchmarks included task time (352 s), path-length (1315 cm), and number of movements (532) for the unguided module. Validated modules were used for curriculum construction with proficiency benchmarks used as performance goals.
Conclusion: A VR simulation model of LA was validated as a training and assessment tool. Consequently, the first evidence-based training curriculum for LA was constructed that facilitates skill acquisition to proficiency.
VALIDATION OF A MOBILITY ASSESSMENT TOOL IN GASTROINTESTINAL SURGICAL PATIENTS
R Holmes,1 SR Smith,1,2 R Carroll2 and P Pockney1,2
1University of Newcastle, Newcastle, Australia; 2John Hunter Hospital, Newcastle, Australia
Introduction: The advent of ‘fast track’ surgery has led to a heightened interest in length of hospital stay as a marker of surgical quality. Comparisons of length of stay between institutions and clinical trials remain difficult due to a lack of defined discharge criteria. The DeMorton Mobility Index (DEMMI) is a means of measuring functional mobility, which has been shown to be a valid scoring mechanism for the purpose of rehabilitation medicine. The aim of this study was to determine whether the DEMMI scoring system is a valid measure of functional recovery and readiness for discharge following surgery.
Methods: The DEMMI score was calculated daily post-op, for 3 days, on 120 patients enrolled in a prospective randomized clinical trial assessing local anaesthetic abdominal blockade, in patients undergoing gastrointestinal surgery. Comparison was then made between DEMMI score and length of hospital stay.
Results: DEMMI scores rose consistently with time, and were easy to perform. 77% of patients who returned to a value of at least 90% of their preoperative DEMMI score were discharged within 72 hours of this reading. Spearman’s correlation revealed a weak association between DEMMI and length of stay (–0.12; two sided p value 0.181).
When emergency operations (ASA-E) and severe complications (Clavien-Dindo Score ≥ 3) were excluded, there is a much stronger association between DEMMI and length of stay (–0.464′ two sided p value ≤ 0.0001).
Conclusion: The DEMMI score provides a measure of mobility that may be useful for assessing post-operative recovery in surgical patients, and provide an objective comparison between unit outcomes and those reported in clinical trials. Correlation between DEMMI and length of stay, in the context of elective gastrointestinal surgical patients with a normal post-operative course is strong.
SIGNIFICANT ELEVATIONS OF SERUM LIPASE NOT CAUSED BY PANCREATITIS – A SYSTEMATIC REVIEW
AM Hameed, WT Lam and HC Pleass
Westmead Hospital, Department of Surgery, New South Wales, Australia
Introduction: Many authors advocate lipase as the preferred serological test for the diagnosis of pancreatitis, with an often quoted cut-off of ≥ 3 times the upper limit of normal (ULN). There exists no systematic review in the literature that explores alternative causes of lipase ≥ 3 times the ULN, which was therefore the objective of this study.
Methods: The Embase and Medline databases (1985 to August 2014, respectively) were searched for all eligible articles. Pre-determined data was extracted and independently analysed by two reviewers.
Results: In total, data from 58 studies was included in the final analysis. The following causes of lipase levels ≥ 3 times the ULN other than pancreatitis were found: reduced clearance of lipase due to renal impairment or macrolipase formation; other hepatobiliary, gastroduodenal, intestinal and neoplastic causes; critical illness, including neurosurgical pathology; alternative pancreatic diagnoses, such as non-pathological pancreatic hyperenzymaemia; and miscellaneous causes such as diabetes, drugs, and infections.
Conclusions: A series of differential diagnoses for significant serum lipase elevations (i.e. ≥ 3 times the ULN) has been provided by this study. Clinicians should utilize this knowledge in the interpretation and management of patients who have lipase levels ≥ 3 times the ULN, remaining vigilant for an alternative diagnosis to pancreatitis. The medical officer should be aware of the incorrect diagnosis in the asymptomatic patient.
SAFETY AND EFFICACY OF LAPAROSCOPIC CHOLECYSTECTOMY IN THE MORBID AND SUPER OBESE PATIENTS
J Oh and L Tiong
Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia
Introduction: Laparoscopic cholecystectomy (LC) in the obese patients can be a challenging procedure for any surgeon. Although LC has been established as the gold standard treatment for symptomatic cholelithiasis, its safety and efficacy in the morbid/super obese patients is still unknown. The aim of this study is to investigate the safety and efficacy of elective LC in the morbid/super obese patients.
Methods: A retrospective review of the Lyell McEwin Hospital electronic database and medical records was conducted searching for all patients who underwent elective LC from 2010–2013. The data collected include patient demographics and BMI, length of hospital stay (LOS), duration of operation, peri-operative complications, bile duct injuries and open conversion rates.
Results: A total of 799 patients (76% female) with a mean age of 46 years and BMI of 31 were included in this study. The average duration of surgery was significantly longer in the morbid/super obese patients compared to those with normal BMI (85 vs 70 minutes, p < 0.05). There were no significant differences in the LOS, peri-operative complication rates, open conversions or bile duct injuries among the BMI groups.
Conclusion: This study showed that LC can be performed safely for symptomatic cholelithiasis in the morbid/super obese patients.
USING SERUM BIOMARKERS TO PREDICT ANASTOMOTIC LEAKAGE: A SYSTEMATIC LITERATURE REVIEW
BU Su’a, H Mikaere, A Taneja and AG Hill
South Auckland Clinical School, The University of Auckland, Middlemore Hospital, Otahuhu, Auckland, New Zealand
Introduction: Anastomotic leakage (AL) following colorectal surgery is a dreaded complication associated with significant morbidity and mortality. The diagnosis of AL, however, remains a clinical dilemma due to its non-specific presentation. An objective systemic biomarker emulating the intra-abdominal milieu surrounding the anastomosis would allow earlier AL diagnosis and expedite effective treatment. This systematic review aims to evaluate the effectiveness of serum biomarkers used in the diagnosis of AL following colorectal surgery.
Methods: A comprehensive review was conducted according to the guidelines in the PRISMA statement. All published studies evaluating serum biomarkers for the diagnoses of AL, were searched in three electronic databases (MEDLINE, PUBMED and EMBASE), from 1980 to July 2014. Clinical outcomes, serum biomarkers and their respective predictive analyses were extracted.
Results: Thirteen studies evaluating 10 different serum biomarkers met the inclusion criteria. Analysis of the biomarkers (immunological, inflammatory and ischaemic), showed that these can reliably predict AL, though with significant variability. The changes in serum concentrations of these biomarkers often precede AL; however, these were limited to small or retrospective studies.
Conclusion: The review demonstrates that measuring serum biomarkers has the potential to predict AL following colorectal surgery. Prospective studies with larger numbers of participants should be performed to determine the diagnostic utility of this approach.
AORTIC ANEURYSM TRIALS IN OCTOGENARIANS: ARE WE REALLY MEASURING THE OUTCOMES THAT MATTER?
S Aitken, V Naganathan and F Blyth
The University of Sydney, Concord Clinical School, Medical Education Centre, Building 26, Concord Hospital, Hospital Road, Concord West, New South Wales, Australia
Introduction: This study aims to systematically review the types of outcomes reported in abdominal aortic aneurysm (AAA) trials of patients aged 80 and over. Specifically, it examines if patient-centred outcomes have been evaluated in studies of AAA surgery in people aged 80 and over.
Methods: A systematic review of open and endovascular AAA interventions with outcome data on patients aged 80 and over was conducted. Relevant articles were identified from searching the databases MEDLINE and EMBASE from 2000–2014. Articles were categorized according to structure, process or outcome indicators (using Donabedian’s framework for health quality indicators). Outcomes were further classified into procedural, complication, resource usage or patient-centred indicators.
Results: 40 studies reported outcomes of elective AAA surgery in patients 80 years and over and were predominantly endovascular repairs (66%, n = 24). The average study size was 167 participants, with a mean age of 84 years. Patient-centred outcome indicators were infrequently reported (13%, n = 5), with limited outcomes of specific relevance to geriatric patients. No studies used validated assessment methods for physical function, activities of daily living or cognition. The majority of studies report short-term mortality results (95%, n = 38), complications (85%, n = 34) and resource usage indicators (60%, n = 24).
Conclusion: The reporting of outcomes after aortic surgery in older patients requires a renewed focus upon outcome indicators of primary importance in clinical decision-making for geriatric patients. Quality and safety indicators already in use in other studies of older patients should be adapted to the specific needs, preferences and values of this cohort.
QUANTITATIVE CHARACTERISATION AND NEUROCHEMICAL CODING OF THE NORMAL HUMAN HINDGUT MYENTERIC PLEXUS
KS Ng,1,2 DA Mahns3 and MA Gladman1,2
1Academic Colorectal Unit, Sydney Medical School, Concord, University of Sydney, New South Wales, Australia; 2Enteric Neuroscience and Gastrointestinal Research Group, ANZAC Research Institute, University of Sydney, Australia; 3Department of Integrative Physiology, School of Medicine, University of Western Sydney, New South Wales, Australia
Introduction: Current understanding of the human enteric nervous system (ENS) remains limited as most existing knowledge is derived from animal and/or human studies utilizing inaccurate techniques (unpaired tissue-sections) rather than ‘gold-standard’ paired wholemount preparations. This study aimed to quantitatively investigate and neurochemically code the human hindgut myenteric plexus using paired wholemount techniques.
Methods: Paired (same-patient) human colon/rectum were procured from anterior resection specimens. Wholemounts of myenteric plexi were prepared by dissecting mucosa/submucosa/circular muscle layers off the longitudinal muscle. Neuronal triple immunostaining was performed with fluorescent-labelled anti-Hu/NOS/ChAT antibodies. Wholemount images (∼100 mm2) were acquired by motorized epifluorescence microscopy, allowing assessment of ganglionic density/size, ganglionic area density, and neuronal density. ‘Stretch-corrected’ values were calculated using stretched/relaxed tissue dimensions.
Results: 12 paired colon/rectum samples were studied. Fluorescent dyes identified 3 subsets of neurons and ganglia, allowing their quantification. Colonic and rectal stretch-corrected ganglionic densities were similar (colon: median 564 ganglia/100 mm2 [range 386–921], rectum: 581 [360–923]; P = 0.70), as were average ganglionic sizes (colon: 57,047 μm2 [42,350–90,363], rectum: 52,021 [38,701–90,210], P = 0.43). Whilst ganglionic area density tended to be lower in the rectum (colon: 11.96 mm2/100 mm2 [7.53–18.64], rectum: 9.76 [5.80–17.19], P = 0.12), there was no difference in stretch-corrected neuronal densities (colon: 176.3 neurons/mm2 [107.4–357.3], rectum: 174.7/mm2 [94.7–313.3], P = 0.58).
Conclusion: This is the first study to quantitatively assess the human hindgut myenteric plexus using paired wholemount immunostains accounting for tissue stretch. Despite differences in function, the ENS of the human colon and rectum is similar in terms of ganglionic density/size, ganglionic area density and neuronal density.
RESTORING EXPRESSION OF MICRORNA-7 INHIBITS THE MAPK AND MTOR PATHWAYS AND OFFERS A NOVEL THERAPY FOR ADRENOCORTICAL CANCER
AR Glover, JT Zhao, J Weiss, JC Ip, G Reid, BG Robinson, AJ Gill, PSH Soon, H Brahmbhatt, JA Macdiarmid and SB Sidhu
Kolling Institute of Medical Research, University of Sydney, Royal North Shore, Hospital and Engeneic Ltd, Sydney
Introduction: Adrenocortical cancer (ACC) has a poor prognosis with limited treatment options. MicroRNA-7 (miR-7) is significantly under-expressed in ACC but it is not known if this is a part of ACC pathogenesis. We sought to establish the functional role of miR-7 as a tumour suppressor and assess miR-7 replacement as novel treatment.
Methods: miR-7 was transfected in ACC cell lines (H295R, SW-13) and compared to negative control (microRNA scramble sequences) transfected cells. A mouse xenograft model using H295R and primary ACC cells was treated by microRNA replacement by intravenously administered bacterially derived EGFR targeted EnGeneIC nanoparticle delivery vehicles (EDVs).
Results: miR-7s role as a tumour suppressor in vitro was confirmed after replacement lead to substantial reductions in cell proliferation and migration (P < 0.05). Flow cytometry showed mean 8.1% and 15.7% increase in G1 arrest in H295R and SW13 cells following miR-7 replacement respectively (P < 0.05). miR-7 predicted targets, EGFR and C-Raf, showed a reduction of 2-fold of both mRNA and protein expression (P < 0.05). Co-transfection of the luciferase reporter vector containing 3′-UTR of EGFR or C-Raf, along with miR-7 mimics suppressed luciferase activity by 50% (P < 0.05) confirming miR-7 targeting. Systemic miR-7 replacement delivered by EDVs in both mouse xenograft models caused a significant reduction in tumour growth with no evidence of toxicity and 2-fold target mRNA knock down of C-Raf, mTOR and CDK1 (P < 0.05).
Conclusion: miR-7 acts as a tumour suppressor in ACC by inhibiting MAPK and mTOR pathways. MicroRNA replacement therapy delivered by EDVs offers a novel treatment of this deadly malignancy.
THERAPEUTIC REDUCTION MAMMOPLASTY – ONCOLOGICAL EFFICACY AND DESCRIPTION OF SURGICAL OPTIONS
D Kamalapurkar, S Syed and U Majeed
Calvary Hospital, Canberra, Australian Capital Territory, Australia
Introduction: Therapeutic reduction mammoplasty (TRM) offers an oncological and cosmetic advantage within the same operation. Our aim was to analyse this in our case series and describe the surgical options used.
Methods: Retrospective review of a single surgeons database on TRM was performed by viewing case-notes, operations and pathology report.
Results: In 37 female patients 38 TRM were carried out from November 2011 to August 2014, average age 56 years (IQR 45–65 years, range 37 to 81 years). The resection margins were positive in 7% (n = 3). Mean tumour size was 23 mm (IQR 12–30 mm, range 6–55 mm) and mean weight of total excised tissue was 209 g (IQR 76–262 g, range 20–710 g). Distribution of T staging was Tis – 17% (n = 7), T1 – 38% (n = 15), T2 – 38% (n = 15) and T3 – 7% (n = 3). Return to theatre for 2 patients – one immediate postoperative haematoma and one debridement of non-viable skin at T-junction of inferior pedicle flap. Cellulitis seen in 2 patients responded to treatment with antibiotics. The surgical approach for reduction was via inferior pedicle in 71% (n − 27), superior pedicle in 10% (n = 4), inferolateral in 10% (n = 4), superolateral in 5% (n = 2) and one ‘round-block’ technique. In 68% (n = 26) of patients, the axilla could be accessed via the same incision as for TRM.
Conclusion: In our series of patients, a low rate of 7% positive margin was seen1. Therapeutic mammoplasty was extended to patients with T3 staging2. The TRM incision approach was feasible for accessing the axilla and reasonably low complication rates were noted.
TRAUMATIC COLONIC INJURIES IN WESTMEAD HOSPITAL – A PARADIGM SHIFT IN MANAGEMENT OVER 10 YEARS
A Lorenzo,1 H Pham,1 B Nguyen,2 T Ei-Khoury,2 N Pathmanathan,2 P Loder,2 G Ctercteko2 and J Hsu3,4
1Department of Surgery, Westmead Hospital, New South Wales, Australia; 2Department of Colorectal Surgery, Westmead Hospital, New South Wales, Australia; 3Trauma Service Department, Westmead Hospital, New South Wales, Australia; 4Discipline of Surgery, University of Sydney, New South Wales, Australia
Introduction: Management of penetrating colon injuries has evolved significantly over the past two centuries, with a trend towards less radical treatment, without faecal diversion and primary repair. There is strong evidence that most colon injuries from civilian trauma can be successfully managed with primary anastomosis. This is a cohort study of the management of penetrating colon injury at Westmead Hospital over the past 10 years.
Methods: Retrospective review of patients admitted with penetrating traumatic colon injuries from 1 January 2003 to 31 December 2013 at Westmead Hospital. Study parameters include demographics, site of colon injury, type of weapon used, injury to admission time, injury to surgery time, penetrating abdominal trauma index (PATI), duration of operation, injury severity score (ISS), surgical management, complications, and length of hospital stay (LOS). A ‘P value’ of less than 0.05 will be considered to be statistically significant.
Results: A total of 55 patients were included in the study with a median age of 38 years (range 15–61 years). Majority of the patients were males (43/55, 78%). The transverse colon was the most common site of injury (53%) and the kitchen knife was the most common weapon used (58%). Primary repair was performed in 63.4% (35/55), resection and anastomosis in 21.8% (12/55) and faecal diversion was performed in 11.4% (5/55). There as a decreasing trend to use diversion ostomy within the 10 year period when compared to both primary repair and primary anastomosis, P = 0.03. There were no significant changes in the trend of complications.
Conclusion: From 2003 to 2013, there is a shift of management of penetrating colonic injuries from diversion to that of primary anastomosis and repair, with primary repair deemed as safe.
DISEASE RECURRENCE AND SURVIVAL IN PATIENTS WITH MULTIFOCAL BREAST CANCER – 7 YEARS RESULTS
LL Kuan, LU Tiong, R Parkyn, D Walters, C Lai and DCA Walsh
Breast and Endocrine Surgery Unit, The Queen Elizabeth Hospital, South Australia, Australia
Introduction: A few studies have shown that multifocal breast cancer (MBC) has poorer outcomes compared to unifocal breast cancer. There is currently no long term data on disease recurrence and survival in patients with MBC. The aim of this study is to evaluate whether patients with MBC have worse outcomes compared to unifocal breast cancer in respect to disease recurrence and survival.
Methods: This is a retrospective study of patients diagnosed with stage I–III MBC from 2000–2007 in comparison to unifocal disease with a median follow up of 7 years. Prognostic factors were prospectively collected and obtained from the breast cancer unit database. Cox proportional hazards models were used to compare the rate of recurrence in the multifocal and unifocal breast cancer groups. Recurrence and overall survival rates were drawn from Kaplan–Meier curves.
Results: A total of 152 patients were included in this study; 75 with multifocal and 77 with unifocal breast cancer respectively. Breast cancer recurred in 9 (11.7%) patients in the unifocal group and 9 (12%) patients in the multifocal group respectively (HR: 1.13, 95% CI: 0.45–2.86, p = 0.794). There were 10 (13%) mortalities in the unifocal group, as compared to 11 (14.7%) in the multifocal group (HR: 1.02, 95% CI: 0.42–2.48, p = 0.969). There were no statistically significant differences in the all-cause mortality and disease recurrence rates between the unifocal and the MBC groups.
Conclusion: This study shows that there were no statistically significant differences in disease recurrence or mortality rates between multifocal and unifocal breast cancer patients after a median follow-up of 7 years.
LPA SIGNALLING CONTRIBUTES TO GLIOMA STEM CELL MIGRATION
W Ng,1,2,5 A Pebay,2,4 DV Brown,2 N Kountouri,1,2 KJ Drummond,1,2,5 AW Burgess,2,3 GM D’Abaco,2 R Luwor,1,2,5 F Frisca,2 AH Kaye1,2 and AP Morokoff1,2
1Department of Surgery, Royal Melbourne Hospital, Parkville, Victoria, Australia; 2University of Melbourne, Parkville, Victoria, Australia; 3Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; 4Centre for Eye Research Australia, Fitzroy, Victoria, Australia; 5Melbourne Brain Centre, Royal Melbourne Hospital, Parkville, Victoria, Australia
Introduction: Molecular targeting in GBM treatment is of intense interest and lysophosphatidic acid (LPA) signalling has been putatively described as having a mechanistic role in cancer invasion1. Initially described for its promotile effects in melanoma cells, it has since been described as a mediator of breast and ovarian cancer metastasis, with LPA inhibition able to retard metastases in murine breast cancer models2,3,4. ATX/LPA receptor expression can be dysregulated in GBM and ATX expression has been shown to be differentially higher at the invasive edge, suggesting LPA signalling may modulate glioma cell invasion5,6,7.
Methods: Patient-derived tumour explants were grown in neural stem cell neurosphere conditions. Relative mRNA expression of cell markers to assess stemness (NES, PROM1, SOX2 and POU5F1) and differentiation (GFAP and TUBB3) were measured using RT-qPCR. Relative mRNA expression of ATX/LPAR was also measured using RTqPCR. Migration was assessed using 24 well transwell plates and either a luciferase reporter gene assay or LDH assay.
Results: In our panel of glioma stem-like cells (GSC), LPA receptors are differentially expressed. In particular, LPAR1 mRNA is commonly over-expressed compared to control neural stem cells (p < 0.05). We show that GSC can migrate in a dose-dependent fashion in response to LPA stimulation. This response can be abolished with a selective LPA1/3 antagonist.
Conclusion: LPA stimulates migration in glioma stem-like cells and may represent a novel target for GBM therapy.
Table 1 Migration rates relative to control (100% cells seeded to bottom chamber)
|
|
BSA*
|
LPA 0.1 uM
|
LPA 1 uM
|
LPA 10 uM
|
GSC028
|
2.75%
+/- 0.75%;
p = 1.0, NS
|
4% +/- 1%;
p = 0.36, NS
|
5.5% +/- 1.2%;
p = 0.11, NS
|
15% +/- 1.6%;
p = 0.002
|
GSC035
|
7.75%
+/- 2.3%;
p = 0.7, NS
|
10.75% +/- 2.6%;
p = 0.4, NS
|
32.25% +/- 3.3%;
p<0.0001
|
53.88% +/- 3.9%;
p<0.0001
|
*BSA is the vehicle control
References
1. Moolenaar WH. Lysophospholipids in the limelight: autotaxin takes center stage. J. Cell. Biol. 2002; 158: 197–9.
2. Stracke ML, Krutzsch HC, Unsworth EJ et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 1992; 267: 2524–9.
3. Zhang H1, Xu X, Gajewiak J et al. Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res. 2009; 69: 5441–9.
4. Boucharaba A1, Serre CM, Guglielmi J et al. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc. Natl. Acad. Sci. USA. 2006; 103: 9643–8.
5. Kishi Y1, Okudaira S, Tanaka M et al. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J. Biol. Chem. 2006; 281: 17492–500.
6. Hoelzinger DB1, Demuth T, Berens ME. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J. Natl. Cancer Inst. 2007: 99: 1583–93.
7. Hoelzinger DB1, Nakada M, Demuth T et al. Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion. J. Neurooncol. 2007: 86: 297–309.
FACE AND CONTENT VALIDATION OF A VIRTUAL REALITY SIMULATION MODEL FOR LAPAROSCOPIC APPENDICECTOMY
P Sirimanna,1 R Aggarwal2 and MA Gladman1
1Academic Colorectal Unit, Sydney Medical School – Concord, University of Sydney, Australia; 2Department of Surgery, Faculty of Medicine, McGill University, Montreal, Canada
Introduction: Training using virtual reality (VR) simulators improves operative performance. However, to be useful these simulators must be realistic (face valid) and relevant (content valid). This study aimed to demonstrate the face and content validity of a VR model for laparoscopic appendicectomy (LA).
Methods: Eighteen surgeons (>10 LAs) performed eight tasks using a VR model of a LA on the LAPMentorTM simulator. Participants completed a 23-item questionnaire to evaluate the face and content validity of the VR simulation model, using a 5-point Likert scale.
Results: Of the 18 participants, 16 (89%) agreed or strongly agreed that the VR model was visually realistic and 17 participants (95%) agreed or strongly agreed that it was representative of performing a LA. Specifically, 17 participants (95%) regarded the VR anatomy as accurate and 16 (83%) reported that it was visually comparable to an inflamed appendix. All participants deemed the VR instruments to be visually accurate and 16 (89%) considered instrument movements and camera angles to be authentic. Despite only 4 participants (22%) reporting tactile feedback to be realistic, tissue handling/behaviour was regarded as accurate by 11 (61%). Indeed, 17 participants (95%) agreed that dissection and division of the mesoappendix and appendix was realistic. All participants supported the VR model as a training tool and 17 (95%) supported its use as an assessment tool.
Conclusion: This study demonstrated the face and content validity of a VR model for LA. Therefore, its use as a training and assessment tool for junior surgical trainees deserves further evaluation.
TARGETING MINIMAL RESIDUAL DISEASE IN BREAST CANCER
A Chakrabarti,1 K Leuchowius,2 I Street1,2 and RL Anderson1,3
1Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; 2Cancer Therapeutics, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; 3Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia
Introduction: Breast cancer is an increasingly diagnosed disease in our society1 resulting in the increased prevalence and longevity of cancer survivors. With increased survival, recurrence is a growing challenge and is attributed to the early dissemination of tumour cells. Currently, no targeted therapy exists for minimal residual disease, from which metastases accounts for 90% of cancer related deaths.
Aim: To find new therapeutic targets against dormant disseminated tumour cells.
Method: Using a novel in vitro model of dormancy, tumour cells are seeded on basement membrane and treated with the therapy of choice. A luminescent cell viability reporter is used for the analysis of tumour cell behaviour in response to the chosen therapeutic.
Results: The in vitro model is accurate at determining the in vivo behaviour of a tumour cell line, and is good platform to test potential therapies. Inhibitors of the MAPK pathway were effective at imposing dormancy.
Conclusion: Using the in vitro dormancy model, potential therapies can be screened and tested in a biologically relevant system. This may provide an avenue for the prevention and/or eradication of metastatic breast cancer.
Acknowledgements: Foundation of Surgery, Royal Australasian College of Surgeons, University of Melbourne, Cancer Australia, EMPathy Breast Cancer Network, National Breast Cancer Foundation.
INCIDENCE OF PULMONARY EMBOLUS IN HIGH RISK TRAUMA PATIENTS WITH INFERIOR VENA CAVA FILTERS
R Mohd Rosli,1 L Tiong,2 J Oh,1 C Dobbins2 and P Bautz2
1Acute Surgical Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia; 2Acute Surgery and Trauma Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Introduction: Trauma patients are at risk of venous thromboembolic event (VTE) due to a hypercoagulable state induced by trauma. Although risk of VTE can be reduced with anticoagulation medications, in some high risk trauma patients, the administering of blood thinning agents can be contraindicated such as in patients with intracranial bleeding. In this group of patients, insertion of inferior vena cava filters (IVCf) could be considered as another option for VTE prophylaxis. This study aims to investigate the incidence of pulmonary embolus (PE) in high risk trauma patients who had IVCf inserted.
Methods: A retrospective case series were conducted at the Royal Adelaide Hospital through review of the radiological database of all trauma patients who had IVCf inserted over the last 10 years.
Results: One hundred and thirty-seven high risk trauma patients with IVCf were identified. Of these, 107 patients had IVCf inserted prophylactically, and none were found to have clinically significant PE while the IVCf remained in situ. Ninety-two patients had their IVCf removed, of which four were found to have PE after filter removal.
Conclusion: This study shows that IVCf could be useful in preventing PE in high risk trauma patients when anticoagulation is contraindicated.
VIRTUAL ANATOMY DISSECTION EXPANDS TEACHING OPPORTUNITIES IN POSTGRADUATE SURGICAL EDUCATION
S Aitken, Y Sivakumaran and A Kiat
The University of Sydney, Concord Clinical School, Medical Education Centre, Building 26, Concord Hospital, Hospital Road, Concord West, New South Wales, Australia
Introduction: Anatomy knowledge is a perceived deficit for many junior doctors (JMOs). Furthermore, junior doctors participating in postgraduate anatomy education face many barriers, including cost, time and location. This study explores how virtual anatomy dissection, such as using an Anatomage table, can improve the uptake of junior doctors in postgraduate anatomy education.
Methods: An eight-week virtual anatomy course was designed and taught. The course utilized peer-led teaching methods and was facilitated by senior surgical staff. Where possible, adult education learning methods were applied to clinical scenarios. Models, plastinated specimens, high-resolution digital images and medical imaging enhanced the virtual dissection. A questionnaire provided qualitative assessment, whilst quantitative assessment used a standardized pre- and post-multichoice examination.
Results: Four groups (27 students) have participated since the course commenced in 2013. These represent almost a third of the hospital’s JMO workforce. Students demonstrated improved mean examination results by 12% (95% CI: 5 to 19, P = .003) and greater clinical confidence. All students felt anatomy education (especially dissection) was important but 73% were unlikely to participate in offsite anatomy courses. Clinical workload and course length were also perceived barriers. Students stated that mentoring from senior colleagues was an important feature of the course and made it superior to online courses.
Conclusion: Virtual anatomy teaching can be delivered on location within teaching hospitals. It can help overcome the perceived barriers junior doctors experience in furthering postgraduate anatomy education, especially for students unlikely to do courses offered outside the hospital. The small group interactions within the course enhance the learning experience.
ARHI IS A POTENTIAL MARKER IN BREAST CANCER
A Chakrabarti1 and RL Anderson1,2
1Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; 2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia
Introduction: Breast cancer is an increasingly diagnosed disease in our society1. The increased prevalence and longevity of cancer survivors results in the emerging issue of recurrence. Currently, we are unable to predict those patients that will have recurrent or progressive disease. This may be the key to stratifying the patients that may benefit from adjuvant therapies.
Aim: To assess the prognostic significance of ARHI
Method: An in silico analysis was conducted using multiple data sets top assess clinical applicability. The expression of ARHI was then assessed using tissue microarrays and correlated with clinicopathological data.
Results: The loss of the expression of the tumour suppressor gene ARHI may have prognostic significance in predicting recurrence and/or progression of disease.
Summary: The loos of expression of ARHI may indicate an increased risk of recurrence and/or progression of disease and should be followed up accordingly. Patients who have significant expression loss may benefit most from adjuvant treatments.
Acknowledgements: Foundation of Surgery, Royal Australasian College of Surgeons, University of Melbourne, Cancer Australia